Therapeia, Telix deal

Therapeia granted Telix rights to ACD-101 to treat

Read the full 82 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE